Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells by Kenzaoui, Blanka Halamoda et al.
© 2012 Halamoda Kenzaoui et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2012:7 1275–1286
International Journal of Nanomedicine
Evaluation of uptake and transport of cationic  
and anionic ultrasmall iron oxide nanoparticles  
by human colon cells
Blanka Halamoda Kenzaoui1
Maya R Vilà2
Josep M Miquel2
Feride Cengelli1
Lucienne Juillerat-
Jeanneret1
1Centre Hospitalier Universitaire 
Vaudois (CHUV) and University 
of Lausanne (UNIL), Lausanne, 
Switzerland; 2Leitat Technological 
Center, Barcelona, Spain
Correspondence: Lucienne Juillerat-
Jeanneret 
University Institute of Pathology,  
rue du Bugnon 25, CH-1011 Lausanne, 
Switzerland 
Tel +41 21 314 7173 
Fax +41 21 314 7115 
Email lucienne.juillerat@chuv.ch
Abstract: Nanoparticles (NPs) are in clinical use or under development for therapeutic imag-
ing and drug delivery. However, relatively little information exists concerning the uptake and 
transport of NPs across human colon cell layers, or their potential to invade three-dimensional 
models of human colon cells that better mimic the tissue structures of normal and tumoral colon. 
In order to gain such information, the interactions of biocompatible ultrasmall superparamagnetic 
iron oxide nanoparticles (USPIO NPs) (iron oxide core 9–10 nm) coated with either cationic 
polyvinylamine (aminoPVA) or anionic oleic acid with human HT-29 and Caco-2 colon cells 
was determined. The uptake of the cationic USPIO NPs was much higher than the uptake of the 
anionic USPIO NPs. The intracellular localization of aminoPVA USPIO NPs was confirmed in 
HT-29 cells by transmission electron microscopy that detected the iron oxide core. AminoPVA 
USPIO NPs invaded three-dimensional spheroids of both HT-29 and Caco-2 cells, whereas 
oleic acid-coated USPIO NPs could only invade Caco-2 spheroids. Neither cationic aminoPVA 
USPIO NPs nor anionic oleic acid-coated USPIO NPs were transported at detectable levels 
across the tight CacoReady™ intestinal barrier model or the more permeable mucus-secreting 
CacoGoblet™ model.
Keywords: iron oxide nanoparticles, human colon cells, spheroids, transport, gastrointestinal 
barrier
Introduction
Recent developments of diagnostic and therapeutic technologies in medicine include 
nanotechnologies to improve the early detection and treatment of human diseases.1,2 
However, there is an urgent need to better understand the mechanisms of the   interaction 
of nanomaterials, including nanoparticles (NPs), with living tissues, and to define the 
consequences of these interactions in order to assess the potential risks associated 
with nanotechnologies. In particular, there is a need to define the potential of NPs to 
be internalized by representative cells of tissues, or to be transported across biological 
cell barriers or inside three-dimensional models of either normal or diseased tissues for 
drug delivery and/or theranostic procedures. The development and use of   nanomaterials 
by industry and for therapeutic purposes elevates the potential of human exposure 
through various routes, including the gastrointestinal tract.
Ultrasmall super paramagnetic iron oxide nanoparticles (USPIO NPs) were 
  developed for magnetic resonance imaging (MRI) of the reticuloendothelial   system 
such as the liver, spleen and lymph nodes, for perfusion imaging of the brain, 
  myocardium, and kidney, and for angiography and tumor vascular imaging.3–5 
  Dextran-coated USPIO NPs are now in clinical use for disease detection by MRI. 
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
1275
ORIgINAL RESEARCH
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/IJN.S26865International Journal of Nanomedicine 2012:7
However, there are few reported precedents of the evaluation 
of the uptake and transport of USPIO NPs by human colon 
cells in two-dimensional barrier models or three-dimensional 
cellular models, the intracellular localization of these USPIO 
NPs following uptake, or their effect on the intestinal barrier 
following exposure.6
Multiple applications of USPIO NPs with   different 
  coatings are under development as new contrast and 
  theranostic agents for colon and especially colon cancer 
imaging and treatment.7–9 The imaging purpose that these NPs 
will be used for determines whether they will be required to 
be able to cross biological barriers. To transport therapeutic 
agents and achieve intracellular drug delivery, USPIO NPs 
must be able to be internalized and transported by colon 
cells into deep layers of the tissue. Surface properties, 
charge, size, shape, and the engineered surface functional-
ization of NPs are important for their interactions (such as 
cell uptake,   transport, or stress reactions) with cells.10,11 In 
particular, surface charges and biochemical properties of 
NPs will determine the adsorption of biological molecules, 
the “corona.”12
The present study focused on the interactions between 
USPIO NPs possessing cationic or anionic surface coat-
ings and human colon carcinoma cells. The USPIO NPs’ 
  potential to be taken up by monolayers of the colon cells was 
investigated, as was their ability to invade three-dimensional 
cell spheroid structures of the colon cells. Using electron 
microscopy to detect the NPs’ iron oxide cores, it was pos-
sible to determine their cellular localization. The effect of 
USPIO NPs on colon barrier integrity was demonstrated 
using two different models of the gastrointestinal barrier, 
and the probability of their transport across these intestinal 
barrier models was evaluated.
Methods
USPIO NPs
Oleic acid-coated ultrasmall superparamagnetic iron oxide 
USPIO NPs (oleic acid-coated USPIO NPs) are commer-
cially available and were provided with physicochemical 
characterization by the provider. Oleic acid-coated USPIO 
NPs (Fe3O4, 3% oleic acid coating) were obtained from 
PlasmaChem (PlasmaChem GmbH, Berlin, Germany) as 
an approximately 7% nanosuspension in water, with average 
particle iron oxide core size 8 ± 3 nm, hydrodynamic size 
14–15 nm (determined by DLS), and zeta potential -30 mV 
at pH 7 (values provided by PlasmaChem). The size of the 
iron oxide core was confirmed by transmission electron 
microscopy (data not shown). The size of oleic acid-coated 
NPs in DMEM plus FCS cell culture medium displayed a 
bimodal size distribution of 25 and 150 nm as determined by 
DLS, and this size was stable toward further   agglomeration 
for 3 days (information provided by D Bilanicova and G 
Pojana, University of Venice, Italy; M Dusinska and the 
NanoTEST Consortium, manuscript in preparation).
The preparation and physicochemical characterization of 
polyvinylalcohol/polyvinylamine USPIO NPs (aminoPVA 
USPIO NPs) has previously been described.13–15 Briefly, 
ferrofluid was prepared by alkaline co-precipitation of ferric 
and ferrous chlorides, reflux in nitric oxide-ferrous nitrate, 
and dialysis providing iron oxide nanoparticles   (ferrofluid) of 
9 nm. To obtain aminoPVA-coated USPIO NPs the ferrofluid 
was mixed with poly(vinylalcohol) (PVA), poly(vinylalcohol/
vinylamine)(aminoPVA) at a 10:1 ratio of polymer to iron 
and a 45:1 ratio of PVA to aminoPVA   copolymer (by mass), 
resulting in USPIO NPs of an hydrodynamic diameter of 
25–30 nm and a zeta potential of +25 mV . The iron content 
of the preparations of aminoPVA-coated USPIO NPs and 
oleic acid-coated USPIO NPs was determined by quantitative 
Prussian blue reaction according to a previously described 
protocol.15,16 The size of aminoPVA USPIO NPs size was 
determined in DMEM plus FCS cell culture medium by 
  turbidity and photon correlation spectroscopy (PCS)17 show-
ing that their size remained stable at their initial 40 nm for up 
to 9 days in this medium. No agglomeration was observed. 
AminoPVA-coated and oleic acid-coated USPIO NPs in 
suspension in water were diluted immediately before use in 
cell culture medium and then serially diluted in cell culture 
medium.
Uncoated USPIO NPs immediately agglomerate in 
culture medium containing FCS, resulting in agglomerates 
of large dispersion size with an average size of 910 nm, as 
determined by DLS and electron microscopy.16 Preliminary 
experiments in the absence of cells (empty Transwells) using 
Transwell devices of different membrane pore size and 
composition have shown that these agglomerates are trapped 
on and in the membrane, and cannot be transported even in 
the absence of cells or in the presence of a strong dynamic 
magnetic field. Thus these USPIO NPs were not evaluated 
in the present report.
Cell models and culture conditions
Human HT-29 and Caco-2 colon carcinoma cells from 
the American Type Culture Collection (ATCC, Manassas, 
VA) were grown in Dulbecco’s modified Eagle’s medium 
(DMEM) containing 4.5 g/l glucose, 10% FCS, and antibi-
otics as monolayer cultures (all cell culture reagents were 
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purchased from Gibco, Invitrogen, Basel, Switzerland). 
For three-dimensional cell cultures (spheroids), HT-29 or 
Caco-2 cells were grown in 75 cm2 flasks (Nunclon,   Milian, 
Geneva, Switzerland) until 90% confluent. Cells were 
detached in trypsin-EDTA (Gibco) and grown in complete 
medium in 10 cm diameter low-adherence bacterial-grade 
Petri dishes (Sarstedt, Sevelen, Switzerland) to give three-
dimensional spheroids after 3–4 days of culture. For transport 
experiments using the CacoReady™ model (Readycell, 
Barcelona, Spain), the HT-29 and Caco-2 cells used by the 
company Advancell (Barcelona, Spain) to develop the bar-
rier model were initially obtained from Dr FX Real (Institut 
Municipal d’Investigació Mèdica, Barcelona). Caco-2 cells 
(82.5 × 104 cells/cm2 in 0.3 mL of complete medium in the 
apical upper compartment and 0.9 mL of complete medium 
in the basal chamber of Transwells® inserts) were cultured 
on 24-well polycarbonate filters (Costar, polycarbonate 
  membrane, pore diameter = 3 µm, 24 inserts per plate) for 
14 days in DMEM 1 g/l glucose supplemented with 10% 
FCS, 2 mM glutamine, 1 U/mL penicillin, and 1 U/mL 
  streptomycin, then for 4 days of culture in semi-solid shipping 
medium, and again for 3 days in regular culture medium (for 
a total of 21 days of culture). For the CacoGoblet™ model 
(Readycell, Barcelona, Spain), a mix of equal volumes of 
Caco-2 and HT-29-M6 goblet cells   (metothrexate-adapted 
HT-29-M6 clone) were cultured under the same conditions.
Cell uptake of USPIO NPs
Cells were grown in 48-well plates (Costar) until 75% conflu-
ent, then exposed to USPIO NPs at the concentration and for 
the time indicated. The plates were washed three times with 
saline (0.9% NaCl (w/v)) and cell-associated iron quantified 
as previously described.14–16 Briefly, to quantify cellular iron 
content cell layers were dissolved at room temperature for 
1 hour in 6 N HCl (125 µL/well of a 48-well plate), then 
125 µL of a 5% solution of K4[Fe(CN)6] ⋅ 3H2O (Merck, 
VWR international, Nyon, Switzerland) in H2O was added 
for 10 minutes, and the absorbance was read at 690 nm in 
a multiwell plate reader (iEMS Labsystems, BioConcepts, 
Allschwil, Switzerland). A standard curve of iron chloride 
in 6 N HCl treated under the same conditions was used to 
quantify the amount of cell-bound iron. All experiments were 
performed in triplicate wells, and repeated at least twice.
On the day of the experiment, the spheroids were   centrifuged 
for five minutes at 1000 rpm at room temperature and gently 
mixed with fresh complete medium containing aminoPVA 
USPIO NPs (final iron concentration = 21 µg/mL) or oleic 
acid-coated USPIO NPs (final iron concentration = 45 µg/mL), 
and incubated with the USPIO NPs in a 10 cm diameter dish 
for either 2 hours or 24 hours, centrifuged for 5 minutes at 
1000 rpm, washed twice with 5 mL phosphate-buffered saline, 
and then centrifuged for 5 minutes at 1000 rpm. The spher-
oid pellet was fixed in 4% buffered formaldehyde (Merck, 
Darmstadt, Germany) for 30 minutes at room temperature, 
centrifuged for 10 minutes at 1000 rpm, and then fixed in 
the cell block preparation system (Shandon Cytoblock® Kit, 
Thermo   Scientific, Pittsburgh, PA), centrifuged for 5   minutes 
at 1500 rpm (Cytospin 3, Shandon), dehydrated and embed-
ded in paraffin, and then histological slides (5 µm) were 
prepared.
Histochemical determination of iron
After exposure to USPIO NPs the cell layers or the spher-
oids were washed with saline, fixed in 4% buffered 
  paraformaldehyde at 4°C for 30 minutes, and incubated 
for 20 minutes at room temperature with a 1:1 solution 
of 1 M HCl and 10% K4[Fe(CN)6] ⋅ 3H2O in H2O, washed 
with distilled water, counterstained with Nuclear Fast Red, 
  dehydrated in graded ethanol to xylol, and mounted. Slides 
were photographed under a Nikon digital camera (DXM 
1200; Nikon Corporation, Tokyo, Japan).
Evaluation of cell viability
Cells were grown in 48-well cell culture plates (Costar, 
Corning, NY) until 75% confluent, exposed to USPIO 
NPs at the concentration and for the time indicated, then 
washed in saline. Cell viability was evaluated using the 
3,4,5-dimethylthiazol-yl-2,5-diphenyl tetrazolium   bromide 
(MTT) assay (Sigma-Aldrich, Buchs, Switzerland) 
added to the cells in fresh complete culture medium at a 
250 µg/mL final concentration. After 2 hours the supernatant 
was removed, and the precipitated formazan was dissolved 
in 0.1 N HCl in isopropanol and quantified at 540 nm in a 
multiwell plate reader (iEMS Labsystems).
Transmission electron microscopy  
and elemental analysis
At the end of exposure to the USPIO NPs, the cells were 
washed twice with phosphate-buffered saline, fixed in 
2% glutaraldehyde buffered in 0.1 M cacodylate for 1 hour at 
4°C, then washed in 0.2 M cacodylate at 4°C (three times for 
10 minutes), gently scraped in 0.2 M cacodylate, and harvested 
by centrifugation (5 minutes at 1000 rpm). The pellets were 
coated with agarose (type III low gelling temperature, Sigma) 
and cut in small pieces. The samples were postfixed in 1%–2% 
buffered osmium tetroxide for 1 hour at room temperature, 
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washed in 0.2 M cacodylate (twice for 5   minutes), dehydrated 
in graded ethanol (twice for 10 minutes in 70% ethanol, 
twice for 10 minutes in 90% ethanol, and three times for 
20 minutes in 100% ethanol), dehydrated again in propylene 
oxide (twice for 30   minutes), embedded in equal volumes of 
propylene oxide and Epon (50% Epon 812   substitute, 26% 
  dodecenylsuccinic anhydride, 23% methyl nadic anhydride, 
1% 2,4,6-tris(dimethylaminomethyl)phenol) (all figures w/w, 
all materials from Fluka, Buchs, Switzerland) for 1 hour, and 
then for 16 hours in Epon.
Specimens were embedded in Epon blocks that were 
cured for 48 hours at 60°C, and then trimmed and cut into 
100 nm sections and mounted on slides for post-visualization 
by methylene blue/azur blue staining. Thin sections (50 nm) 
were cut from the cured blocks using an ultramicrotome 
(Ultracut E, Reichert-Jung Optische Werke AG, Wien, 
Austria) and mounted on 3-mm 200-mesh copper grids. 
Grids were heavy-metal stained using a standard two-step 
uranyl acetate/lead citrate technique (Leica EM Stain) and 
then examined and photographed at 80 kV with a Philips 
CM12 transmission electron microscope (Amsterdam, The 
Netherlands) combined with a MegaView III, Soft Imaging 
System (Gloor Instruments, Uster, Switzerland). Elemental 
  analysis of iron was performed by an electron detection 
X-ray (EDAX, EDX-4), coupled to the CM12 transmission 
electron microscope.
USPIO NPs transport
Evaluation of the transport of USPIO NPs by CacoReady 
and CacoGoblet was performed after 21 days of culture 
when the cells were completely differentiated as assessed 
by transepithelial electrical resistance measurements. Both 
the apical and basal chambers were washed twice with Ca2+/
Mg2+ Hank’s balanced salt solution (HBSS) buffer (Gibco) 
supplemented with 5 mM glucose. USPIO NPs (100 µg/mL 
or 70 µg/mL iron) diluted in HBSS buffer were applied to 
the apical chambers while basal   chambers were filled with 
HBSS buffer without USPIO NPs. After 0, 2, 6, and 24 hours 
of incubation, 50 µL of medium was removed from the basal 
chambers and analyzed for iron content with the Prussian 
blue reaction (see above). The   volume in the basal chamber 
was maintained by adding 50 µL of fresh medium after each 
sampling point. Parallel experiments were performed in the 
absence of cells (empty membranes). The effect of USPIO 
NPs on CacoReady and CacoGoblet barriers was assessed 
by Lucifer yellow permeability measurement after the end 
of the assay (24 hours of exposure to USPIO NPs). Lucifer 
Yellow-HD (Sigma-Aldrich) solution at a final concentration 
of 200 µM in HBSS buffer was added to the apical chamber 
and incubated for 1 hour at 37°C, and 100 µL of the medium 
in the basal compartment was analyzed in a multiwell plate 
fluorescence reader at 485 nm/530 nm   excitation/emission 
wavelength, respectively.
Statistical analysis
Each experiment was repeated in triplicate wells at least 
twice. Means and standard deviations (SDs) were calculated, 
and statistical significance was assessed using Student’s 
t-test.
Results
Uptake of USPIO NPs by monolayers  
of human colon cells
Previous research has shown that positive charges at the   surface 
of aminoPVA-USPIO NPs are necessary for their uptake by 
cells, including human cells, since   aminoPVA-coated (but 
not carboxylate-PVA-coated or PVA-coated) USPIO NPs 
were internalized by the cells.14,16 Therefore, the association 
of these previously described cationic aminoPVA USPIO NPs 
(Figure 1) with HT-29 and Caco-2 human colon cells was 
compared to their   association with anionic oleic acid-coated 
USPIO NPs (Figure 2), as determined through the evaluation 
of cell-associated iron by histological or quantitative   Prussian 
blue reaction. In both cell lines, the association of   aminoPVA 
USPIO NPs dose-dependently increased with time (  Figure 1), 
while anionic USPIO NPs were only poorly associated with 
colon cells and this association did not increase with longer 
exposure time (Figure 2). For these USPIO NPs, the iron 
content in the cell layers was below the detection limit of 
the Prussian blue method. Therefore, cationic USPIO NPs 
associated with human colon cells to a larger extent than 
anionic USPIO NPs. Similar results were obtained in both 
cell lines (data of the histological   Prussian blue reaction are 
not shown for HT-29 cells).
An MTT test was used to evaluate cell metabolic activity 
to determine whether uptake resulted in a cytotoxic effect for 
the cells. Neither aminoPVA nor oleic acid-coated USPIO NPs 
inhibited cell metabolic activity except for the highest con-
centrations of oleic acid-coated USPIO NPs tested (Figure 3A 
and B) in both cell lines after 24 hours of exposure.
It was demonstrated through the use of transmission 
electron microscopy that the iron oxide core of these 
aminoPVA USPIOs was localized in granular structures 
inside HT-29 cells, with microscopy performed after either 
6 hours (Figure 4A) or 24 hours (Figure 4B). The presence 
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of iron was confirmed after 24 hours by elemental analysis 
(Figure 4D), and it was found that more iron was associ-
ated with HT-29 cells and that this was located closer to 
the nucleus after 24 hours. For the purpose of comparison, 
cell-associated iron was quantified by quantitative Prussian 
blue reaction (Figure 4C).
Uptake of USPIO NPs by spheroids  
of human colon cells
HT-29 cells form well-structured spheroids.  After 2 or 24 hours’ 
exposure, it was determined whether aminoPVA USPIO NPs 
have the potential to invade three-dimensional spheroids of 
HT-29. The results showed that the iron oxide core of very 
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Figure 1 Time-dependent uptake of aminoPVA-coated USPIO NPs by Caco-2 and HT-29 cells. (A) Caco-2 cells were grown to 75% confluence, then were exposed for 6 or 
24 hours in complete culture medium to 20 µg/mL aminoPVA USPIO NPs. Then cells were stained with Prussian blue and Nuclear Red histological stains (iron blue, nucleus 
red, cytoplasm pink). (B) Caco-2 and HT-29 cells were grown to 90% confluence, then they were exposed for 6 hours (grey line) or 24 hours (black line) in complete culture 
medium to increasing concentrations of aminoPVA USPIO NPs and the cell-associated iron content of the cell layer was quantified using the Prussian blue reaction.
Abbreviations: aminoPVA, polyvinylamine; USPIO NPs, ultrasmall superparamagnetic iron oxide nanoparticles.
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few aminoPVA USPIO NPs could be detected by the Prussian 
blue reaction at the surface of the spheroids after 2 hours’ 
exposure, whereas after 24 hours’ exposure a large number of 
aminoPVA USPIO NPs could be demonstrated at the surface 
as well as in deeper layers of the spheroids (Figure 5A). This 
demonstrated their potential to invade three-dimensional 
colon tissue structures.
The invasion of spheroids of either HT-29 or Caco-2 cells 
was compared after 24 hours by aminoPVA USPIO NPs 
and oleic acid-coated USPIO NPs (Figure 5B). Caco-2 cells 
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Figure 2 Time-dependent uptake of oleic acid-coated ultrasmall superparamagnetic iron oxide nanoparticles (USPIO NPs) by Caco-2 and HT-29 cells. (A) Caco-2 cells were 
grown to 75% confluence, then were exposed for 6 or 24 hours in complete culture medium to 20 µg/mL oleic acid-coated USPIO NPs. Then cells were stained with Prussian 
blue and Nuclear Red histological stains (iron blue, nucleus red, cytoplasm pink). (B) Caco-2 and HT-29 cells were grown to 90% confluence, then they were exposed for 
6 hours (grey line) or 24 hours (black line) in complete culture medium to increasing concentrations of oleic acid-coated USPIO NPs and the cell-associated iron content of 
the cell layer was quantified using the Prussian blue reaction.
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Figure 3 Cytotoxicity of aminoPVA- and oleic acid-coated USPIO NPs for colon 
carcinoma cells. Caco-2 cells (black line) and HT-29 cells (grey line) were exposed 
for 24 hours to aminoPVA-coated (A) and oleic acid-coated (B) USPIO NPs, then 
an MTT test was performed to ascertain cytotoxicity.
Notes: Means ± standard deviation were calculated, and statistical significance was 
assessed using Student’s t-test; *P , 0.05, exposed cells compared to control cells
Abbreviations: aminoPVA, polyvinylamine; USPIO NPs, ultrasmall superpara-
magnetic iron oxide nanoparticles.
form smaller and less cohesive spheroids than HT-29 cells. 
Whereas the presence of the iron oxide core of aminoPVA 
USPIO NPs was observed inside spheroids of both cells, the 
presence of the iron oxide core of oleic acid-coated USPIO 
NPs was observed only in spheroids of Caco-2 cells.
Transport of USPIO NPs by colon cells
The ability of two different cellular experimental models of 
the gastrointestinal barrier (the tight CacoReady model and 
the more permeable mucus-secreting CacoGoblet model) to 
transport cationic and anionic USPIO NPs was evaluated. 
Cells were exposed to the USPIO NPs for 24 hours after which 
LY permeability was assessed, and this demonstrated that the 
presence of USPIO NPs did not affect the integrity of the 
CacoReady and CacoGoblet barriers (results not shown). The 
transport experiments performed for a 24-hour time-course 
showed that whereas the USPIO NPs were transported across 
empty Transwell membranes, neither gastrointestinal barrier 
models efficiently transported the USPIO NPs (Figure 6). The 
noncumulated amount of USPIO NPs in the basal compart-
ment of the device showed that oleic acid-coated USPIO NPs 
transfer less across the membrane than the aminoPVA USPIO 
NPs, with most of the transfer of oleic acid-coated USPIO 
NPs being achieved within 2 hours.
Discussion
The success of a nanoparticle-based therapy depends largely 
on the behavior of the NPs in the tissue microenvironment and 
their interactions with cells forming the tissue. The   present 
study focused on the mechanisms of uptake and   transport 
of cationic and anionic ultrasmall   superparamagnetic iron 
oxide NPs (USPIO NPs) by human colon cells. USPIO 
NPs composed of a 9 nm monocrystalline core coated with 
polyvinylamine/polyvinylalcohol (aminoPVA USPIO NPs) 
for biological compatibility and stability had previously been 
developed.13,14 These cationic aminoPVA USPIO NPs with 
a defined number of positive amino groups at their surface 
have been shown to have the potential to be internalized by 
cells with their polymers15 even when the polymers were 
chemically functionalized with anti-cancer drugs,18,19 and 
that internalization was dependent on the positive charges at 
their surface. In the current study, the behavior toward human 
colon cancer cells of these cationic aminoPVA USPIO NPs 
was compared with anionic oleic acid-coated USPIO NPs 
with comparable core and hydrodynamic sizes. Whereas 
human colon cells efficiently internalized the cationic 
USPIO NPs in a time- and concentration-dependent man-
ner, the uptake of the anionic USPIO NPs was very low (to 
the extent that it was hardly detectable by the Prussian blue 
method) and did not increase with longer exposure times. 
Electron microscopy images of HT-29 cells suggested that 
aminoPVA USPIO NPs were localized intracellularly in the 
endosomal/lysosomal compartment and that they retained 
their initial nanometric dimension for 24 hours. A number of 
recent in vitro and in vivo studies highlight the importance 
of NP surface charge for cellular uptake and biodistribu-
tion,20–22 indicating that for most particles a positive charge 
at their surface enhances cellular internalization,22–24 which 
is very likely linked to the adsorption of different biological 
  molecules at the surface of NPs (the corona) dependent on 
surface charge and chemical characteristics.12
Another important issue when considering NPs for 
therapeutic purposes is their potential to penetrate tissues. 
Three-dimensional cell culture models have been developed 
in order to mimic tissue structure better than is possible with 
two-dimensional monolayer cell cultures. Three-dimensional 
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Figure 4 Cellular localization of aminoPVA-coated USPIO NPs in HT-29 cells. (A) After 6 hours of exposure, transmission electron microscopy images demonstrated that 
the iron oxide core of aminoPVA USPIO NPs (21 µg Fe/mL) was localized in intracellular organelles of HT-29 cells. (B) After 24 hours of exposure the iron oxide core of 
aminoPVA USPIO NPs (21 µg Fe/mL) was localized closer to the nucleus. (C) For the purpose of comparison, cell-associated iron was quantified by quantitative Prussian blue 
reaction. (D) Elemental analysis (dotted arrow) performed confirmed the presence of iron in the area defined by the black square of the transmission electron microscopy 
images (lower panel, right).
Abbreviations: aminoPVA, polyvinylamine; USPIO NPs, ultrasmall superparamagnetic iron oxide nanoparticles.
cell models, such as normal cell aggregates or tumor 
  spheroids, allow researchers to study drug penetration and 
cell-cell interactions.25–29 It has previously been shown that 
aminoPVA USPIO NPs localize exclusively in the first layer 
of nontumoral three-dimensional aggregates of differentiated 
rat brain cells,15 whereas NPs were able to penetrate into 
deeper layers of spheroids of human melanoma cells, likely 
through the use of vasculogenic mimicry structures.30
In the present study, a three-dimensional spheroid model 
system was obtained by growing HT-29 or Caco-2 cells under 
static conditions which resulted in rounded, compacted, 
and regularly shaped spheroids, for all spheroids, however, 
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Figure 5 Polyvinylamine (aminoPVA)- and oleic acid-coated ultrasmall superparamagnetic iron oxide nanoparticles (USPIO NPs) selectively invade three-dimensional spheroids 
of human HT-29 and Caco-2 colon carcinoma cells. (A) Human HT-29 cells in three-dimensional spheroid cultures form well-structured spheroids after 3 days. The spheroids were 
exposed to aminoPVA USPIO NPs (21 µg Fe/mL) for 2 or 24 hours, recovered, fixed, then cell-associated iron was determined on histological slides by the histological Prussian blue 
reaction (iron, blue staining; cell cytoplasm, pink; cell nuclei, red). After 2 hours aminoPVA USPIO NPs were found in very few cells (arrow) of the first layer of the spheroids, but after 
24 hours’ exposure of the spheroids they were more widely found in many cells, including in cells localized more deeply in the spheroids. (left, 100× ; right, 400× magnification). (B) 
Human HT-29 and Caco-2 cells in three-dimensional spheroid cultures were exposed to aminoPVA-coated USPIO NPs (21 µg iron/mL, left panels) and oleic acid-coated USPIO NPs   
(45 µg iron/mL, right panels) for 24 hours, recovered, fixed, then cell-associated iron (arrows) was determined on histological slides by the histological Prussian blue reaction 
(iron, blue staining; cell cytoplasm, pink; cell nuclei, red).
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Figure 6 Transport of ultrasmall superparamagnetic iron oxide nanoparticles (USPIO NPs) by human colon cells. Transport of polyvinylamine (aminoPVA) USPIO NPs   
(A) and oleic acid-coated USPIO NPs (B) across CacoReady™ (white bars) and CacogobletTM (grey bars) colon barriers and across empty membrane (black bars). The initial 
concentration of iron in apical chamber was 100 µg/mL (A) or 70 µg/mL (B). Iron concentration in the basal chamber was quantified with the Prussian blue reaction. 
Note: The results represent noncumulated amounts of iron in the basal compartments at each time-point, without addition of USPIO NPs in the apical compartment.
spheroids from Caco-2 cells were less well structured and 
less cohesive than spheroids from HT-29 cells. Penetration 
of HT-29 cell spheroids was limited to the first cell layers 
after 2 hours of exposure to aminoPVA USPIO NPs, but 
after 24 hours of exposure the aminoPVA USPIO NPs were 
localized in the lower layers of the spheroids. The aminoPVA 
USPIO NPs were also able to invade deep layers of Caco-2 
cell spheroids after 24 hours of exposure. However, oleic 
acid-coated USPIO NPs could only be found in spheroids 
of Caco-2 cells, which were generally smaller and less 
cohesive than HT-29 spheroids. Thus, the uptake by the 
spheroids of oleic acid-coated USPIO NPs was   dependent on 
the cancer cells considered. Therefore, for interactions with 
biological structures both the surface properties of NPs and 
the characteristics of the tissue are important.
However, neither aminoPVA-coated nor oleic acid-
coated USPIO NPs were transported across gastrointestinal 
barriers such as the CacoReady (Caco-2 cells only) or the 
CacoGoblet (Caco-2 cells and HT-29-M6 cells in co-culture) 
colon barrier models. CacoReady represents a tight bar-
rier model while CacoGoblet represents a more permeable 
mucus-secreting barrier model that mimics normal physi-
ological conditions. The differentiated Caco-2 cells alone 
or in co-culture are well characterized cellular models of 
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normal intestinal epithelium.31,32 Monolayers of these cells 
have been widely used to study the unidirectional transport 
of diverse drugs and particles from the apical to the baso-
lateral side, and these results correlate with in vivo experi-
ments.33,34 The major mechanism for drug uptake across 
the intestinal mucosa is passive diffusion where the driving 
force is a concentration gradient. The ionization state of 
the agents is important for transport. The transport of the 
drug valdecoxib entrapped in microspheres was determined 
using this model, but only the drug was analyzed in the 
basolateral side of the Transwell, and the authors postu-
lated drug release prior to transport. No attempt was made 
to evaluate whether the microspheres were transported by 
the cells.35 The current study shows that neither cationic 
  aminoPVA USPIO NPs nor anionic oleic acid-coated USPIO 
NPs were transported across these colon barriers during a 
24-hour evaluation. Thus, the ability of NPs to penetrate 
three-dimensional tissue does not predict their potential to 
cross cellular barriers such as the intestinal barrier. In the 
few available studies dealing with transport issues only a 
small number of the tested NPs (such as lipid nanocapsules 
or chitosan NPs) were successfully transported across the 
intestinal barrier model in vitro.36–38 The mobility of poly-
styrene NPs in the gastrointestinal mucus was shown to be 
strongly dependent on their surface charge and chemistry.39 
The interactions of uncoated, aminoPVA-coated, and oleic 
acid-coated USPIO NPs have been evaluated with human 
brain endothelial cells as a blood–brain barrier (BBB) model, 
with this work showing that while the cells could internalize 
the NPs, none were transported across the BBB model, even 
in the presence of a strong magnetic field.16 Thus, the BBB 
and the gastrointestinal barrier models provided comparable 
information regarding USPIO NPs transport.
Conclusion
USPIO NPs are useful MRI agents in vivo, and when 
functionalized with therapeutic or diagnostic agents – the 
so-called theranostic agents – the distribution of theranostics-
USPIO NPs in a living human will provide information on 
the biodistribution of the theranostics and their ability to 
reach their targets. Thus, the present project aimed to evalu-
ate the surface characteristics of USPIO NPs that allow or 
prevent their uptake by and transport across human colon 
cells. This would allow their potential as drug-delivering 
agents to be evaluated, as well as their potential for invading 
three-dimensional models of human colon cells, which better 
mimic the tissue structures of normal and tumoral colon than 
the two-dimensional models used in the past.
The results presented here show that cationic USPIO 
NPs are more promising than anionic USPIO NPs for their 
  intracellular delivery into human colon cells, but these 
NPs will not cross an intact intestinal barrier whatever 
their charge. Nevertheless, depending on their surface 
charge and the physiological characteristics of the three-
dimensional tissue, they have the potential to invade 
three-dimensional spheroids of human colon carcinoma 
cells (which act as   models of human colon cancer). These 
observations are important for the development of either 
therapeutic and theranostic NPs for the extracellular or 
intracellular delivery of therapeutic agents, or of diagnostic 
NPs for the imaging of diseases of the human gastrointes-
tinal tract.
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